. Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer's Disease. Biomater Res. 2023 Oct 5;27(1):98. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. CST-103